MPP and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries Read more
Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform Read more
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders Read more
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases Read more
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate Read more
PTC Announces Expansion of Translarna Label to Include Ambulatory Patients as Young as 2 Years Old in Brazil Read more
FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD) Read more